115 related articles for article (PubMed ID: 33183200)
1. Recombinant Adeno-associated Virus 9-mediated Expression of Kallistatin Suppresses Lung Tumor Growth in Mice.
Qu W; Zhao J; Wu Y; Xu R; Liu S
Curr Gene Ther; 2021; 21(1):72-80. PubMed ID: 33183200
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of angiogenesis and HCT-116 xenograft tumor growth in mice by kallistatin.
Diao Y; Ma J; Xiao WD; Luo J; Li XY; Chu KW; Fung P; Habib N; Farzaneh F; Xu RA
World J Gastroenterol; 2007 Sep; 13(34):4615-9. PubMed ID: 17729417
[TBL] [Abstract][Full Text] [Related]
3. [Plasmid-mediated expression of kallistatin and its biological activity in lung cancer related cells].
Wang NQ; Zou J; Diao Y
Yao Xue Xue Bao; 2013 Mar; 48(3):359-65. PubMed ID: 23724648
[TBL] [Abstract][Full Text] [Related]
4. Adeno-associated virus-mediated expression of kallistatin suppresses local and remote hepatocellular carcinomas.
Tse LY; Sun X; Jiang H; Dong X; Fung PW; Farzaneh F; Xu R
J Gene Med; 2008 May; 10(5):508-17. PubMed ID: 18338836
[TBL] [Abstract][Full Text] [Related]
5. Plasmid mediated kallistain gene expression via intramuscular electroporation delivery in vivo for treatment of NCI-H446 subcutaneous xenograft tumor.
Jia D; Zheng C; Feng J; Zou J; Diao Y
Pak J Pharm Sci; 2014 May; 27(3 Suppl):633-6. PubMed ID: 24816705
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatin.
Shiau AL; Teo ML; Chen SY; Wang CR; Hsieh JL; Chang MY; Chang CJ; Chao J; Chao L; Wu CL; Lee CH
BMC Cancer; 2010 May; 10():245. PubMed ID: 20509975
[TBL] [Abstract][Full Text] [Related]
7. [Adeno-associated vector mediated intracellular biological activity of human Kallistatin].
Duan XW; Chen SY; Wang F; Cheng ZY; Tang MQ; Xu RA
Yao Xue Xue Bao; 2014 Jul; 49(7):993-9. PubMed ID: 25233629
[TBL] [Abstract][Full Text] [Related]
8. Synergistic antitumor effect of recombinant adeno-associated virus-mediated pigment epithelium-derived factor with hyperthermia on solid tumor.
Wu Q; He S; Wei X; Shao B; Luo S; Guo F; Zhang H; Wang Y; Gong C; Yang L
Hum Gene Ther; 2014 Sep; 25(9):811-23. PubMed ID: 25003563
[TBL] [Abstract][Full Text] [Related]
9. Enhanced efficacy of combination therapy with adeno‑associated virus-delivered pigment epithelium-derived factor and cisplatin in a mouse model of Lewis lung carcinoma.
He SS; Wu QJ; Gong CY; Luo ST; Zhang S; Li M; Lu L; Wei YQ; Yang L
Mol Med Rep; 2014 Jun; 9(6):2069-76. PubMed ID: 24714917
[TBL] [Abstract][Full Text] [Related]
10. AAV-mediated persistent bevacizumab therapy suppresses tumor growth of ovarian cancer.
Xie Y; Hicks MJ; Kaminsky SM; Moore MA; Crystal RG; Rafii A
Gynecol Oncol; 2014 Nov; 135(2):325-32. PubMed ID: 25108232
[TBL] [Abstract][Full Text] [Related]
11. Protection of the liver against CCl4-induced injury by intramuscular electrotransfer of a kallistatin-encoding plasmid.
Diao Y; Zhao XF; Lin JS; Wang QZ; Xu RA
World J Gastroenterol; 2011 Jan; 17(1):111-7. PubMed ID: 21218091
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppressor in lung cancer-1 (TSLC1) mediated by dual-regulated oncolytic adenovirus exerts specific antitumor actions in a mouse model.
Lei W; Liu HB; Wang SB; Zhou XM; Zheng SD; Guo KN; Ma BY; Xia YL; Tan WS; Liu XY; Wang YG
Acta Pharmacol Sin; 2013 Apr; 34(4):531-40. PubMed ID: 23503473
[TBL] [Abstract][Full Text] [Related]
13. [Gene therapy of bladder cancer by using recombinant adeno-associated virus-endostatin: experiments in vitro and in vivo].
Lu BX; Han RF; Tang Y; Han YZ; Li SZ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):802-5. PubMed ID: 17565858
[TBL] [Abstract][Full Text] [Related]
14. AAV-mediated gene transfer of human pigment epithelium-derived factor inhibits Lewis lung carcinoma growth in mice.
He SS; Shi HS; Yin T; Li YX; Luo ST; Wu QJ; Lu L; Wei YQ; Yang L
Oncol Rep; 2012 Apr; 27(4):1142-8. PubMed ID: 22218393
[TBL] [Abstract][Full Text] [Related]
15. Recombinant AAV-mediated HSVtk gene transfer with direct intratumoral injections and Tet-On regulation for implanted human breast cancer.
Li ZB; Zeng ZJ; Chen Q; Luo SQ; Hu WX
BMC Cancer; 2006 Mar; 6():66. PubMed ID: 16539746
[TBL] [Abstract][Full Text] [Related]
16. Combining kallistatin gene therapy and meloxicam to treat hepatocellular carcinoma in mice.
Jiang X; Li H; Qiao H; Jiang H; Xu R; Sun X
Cancer Sci; 2009 Nov; 100(11):2226-33. PubMed ID: 19709125
[TBL] [Abstract][Full Text] [Related]
17. Suppression of bladder cancer growth in mice by adeno-associated virus vector-mediated endostatin expression.
Pan JG; Zhou X; Zeng GW; Han RF
Tumour Biol; 2011 Apr; 32(2):301-10. PubMed ID: 21052889
[TBL] [Abstract][Full Text] [Related]
18. Adeno-associated virus 2-mediated intratumoral prostate cancer gene therapy: long-term maspin expression efficiently suppresses tumor growth.
Watanabe M; Nasu Y; Kashiwakura Y; Kusumi N; Tamayose K; Nagai A; Sasano T; Shimada T; Daida H; Kumon H
Hum Gene Ther; 2005 Jun; 16(6):699-710. PubMed ID: 15960601
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of gastric cancer cell growth in vivo by overexpression of adeno-associated virus-mediated survivin mutant C84A.
Weng Y; Fei B; Chi AL; Cai M
Oncol Res; 2013; 20(9):411-7. PubMed ID: 23924925
[TBL] [Abstract][Full Text] [Related]
20. Adeno-associated virus-mediated doxycycline-regulatable TRAIL expression suppresses growth of human breast carcinoma in nude mice.
Zheng L; Weilun Z; Minghong J; Yaxi Z; Shilian L; Yanxin L; Dexian Z
BMC Cancer; 2012 Apr; 12():153. PubMed ID: 22530952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
